X

Lincoln Pharmaceuticals Ltd Stock Analysis

Small Cap
Evaluated by 895 users | BSE: 531633 | NSE: LINCOLN |
Pharmaceuticals & Drugs
Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 6.73%6.47%8.66%10.3%11.5%13.23%14.04%12.8%16.2%14.73%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 166175192208223311304325353376
Y-o-Y Gr. Rt.-5.4%9.6%8.8%7.1%39.2%-2.1%6.8%8.6%6.5%
Adjusted EPS (Rs.) 2.021.954.637.28.212.1813.6215.0921.8121.61
Y-o-Y Gr. Rt.--3.5%137.4%55.5%13.9%48.5%11.8%10.8%44.5%-0.9%
Book Value per Share (Rs.) 46.8149.1654.4760.7768.2780.3994.79109.77131.3152.25
Adjusted Net Profit 3.33.27.611.713.419.927.230.243.643.2
Net Op. Cash Flow (Rs. Cr.) -33.6104.39.28.828.917.821.351.170.7
Debt to Cash Flow from Ops -1.35614.135.555.492.092.982.630.660.07
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Lincoln Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 9.5%11%7.3%6.5%
Adjusted EPS 30.1%21.4%16.6%-0.9%
Book Value per Share 1417.417.116
Share Price 27% 8.7% 1.8% 75.8%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 5.114.068.9412.512.7115.916.5914.7518.0915.24
Operating Profit Margin (%) 5.697.718.329.1910.4510.5913.9514.2117.1415.92
Net Profit Margin (%) 1.991.823.945.635.996.398.959.2912.3611.49
Debt to Equity 0.590.750.690.510.430.460.280.260.130.02
Working Capital Days 208264270272248168198221223227
Cash Conversion Cycle 787469741089393949080
Entity Percentage Holding
Promoters 37.26%
Non-Institutions 62.74%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Lincoln Pharmaceuticals Ltd's performance infers:

Lincoln Pharmaceuticals Ltd earnings have grown by 21.4%, whereas share price has appreciated 8.7% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Lincoln Pharmaceuticals Ltd share prices over the last 10 years. Here is what we found out:

Lincoln Pharmaceuticals Ltd share price has appreciated 21.4% annually over the past ten years.

Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad.

Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad. The plant spreads across 30,000 square meters. There are three different buildings for tablets, capsules and injectables and also a separate building for quality control.

An ultramodern laboratory with state-of-the-art equipments ensures in-house quality assurance of each of the products. The products are designed for all therapeutic segments with a special emphasis on gynecological and orthopedic specialties.

Group of Companies

  • Lincoln Parenterals
  • Karnavati Distributors
  • Down Town Travels
  • Shelavi Paper Mills

Product of the company

  • Tablets 
  • Capsules
  • Injectables
  • Syrups
  • Ointments

Certification

  • WHO-GMP standard
  • ISO 9002 certification 
  • Export House certification
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback